HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells.

Abstract
Curcumin (Cur), a promising anticancer drug, kills tumor cells through either diminishing or promoting reactive oxygen species (ROS) generation. In this study, it was investigated whether trichostatin A (TSA), a specific histone deacetylase (HDAC) inhibitor and a new anticancer drug, could improve the anticancer activity of low concentrations of Cur in human leukemia cells (HL-60). HL-60 cells were treated with Cur, TSA or their combinations; cell proliferation arrest, lactate dehydrogenase (LDH) release and cell viability were measured as indicators of cell damage. Reactive oxygen species (ROS) accumulation and the acetylation of histones were also measured. The cytotoxicity of Cur and TSA increased in a time and dose-dependent manner. Low Cur (no more than 20 microM) diminished the ROS generation in HL-60 cells, while high Cur (50 and 100 microM) promoted that. In contrast, TSA showed no influence on ROS generation. When their effects on histone acetylation were determined, low Cur showed no effect, while TSA significantly increased that. As expected, combinations of low Cur and TSA could not only diminish ROS generation, but also increase histone acetylation, and hence showed a more significant cytotoxicity in HL-60 cells. Since the extra ROS generation may also harm normal cells, instead of using high Cur, combining low Cur with TSA is obviously a better strategy to improve the anticancer activity of Cur.
AuthorsJie Chen, Hai Bai, Cunbang Wang, Jiuhong Kang
JournalDie Pharmazie (Pharmazie) Vol. 61 Issue 8 Pg. 710-6 (Aug 2006) ISSN: 0031-7144 [Print] Germany
PMID16964716 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Antioxidants
  • Histones
  • Hydroxamic Acids
  • Indicators and Reagents
  • Protein Synthesis Inhibitors
  • Reactive Oxygen Species
  • trichostatin A
  • L-Lactate Dehydrogenase
  • Curcumin
  • Ascorbic Acid
  • Acetylcysteine
Topics
  • Acetylation
  • Acetylcysteine (pharmacology)
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Antioxidants (pharmacology)
  • Ascorbic Acid (pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cell Survival (drug effects)
  • Curcumin (pharmacology)
  • Drug Synergism
  • HL-60 Cells
  • Histones (isolation & purification, metabolism)
  • Humans
  • Hydroxamic Acids (pharmacology)
  • Indicators and Reagents
  • L-Lactate Dehydrogenase (metabolism)
  • Leukemia, Promyelocytic, Acute (drug therapy)
  • Protein Synthesis Inhibitors (pharmacology)
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: